Haemophilia B in a female resulting from two de novo single base substitutions in the factor IX gene

被引：0
|
作者：
Costa, JM
Fressinaud, E
David, A
Moisan, JP
Meyer, D
Lavergne, JM
Vidaud, M
机构：
[1] HOP AMER NEUILLY, PARIS, FRANCE
[2] HEMATOL LAB, NANTES, FRANCE
[3] SERV PEDIAT, NANTES, FRANCE
[4] GENET MOL LAB, NANTES, FRANCE
[5] INSERM, U143, LE KREMLIN BICETRE, FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PS944 / PS944
页数：1
相关论文
共 50 条
  • [41] PARTIAL DELETION BY ILLEGITIMATE RECOMBINATION OF THE FACTOR-IX GENE IN A HAEMOPHILIA-B FAMILY WITH 2 INHIBITOR PATIENTS
    GREEN, PM
    BENTLEY, DR
    MIBASHAN, RS
    GIANNELLI, F
    MOLECULAR BIOLOGY & MEDICINE, 1988, 5 (02) : 95 - 106
  • [42] Factor IX replacement to cover total knee replacement surgery in haemophilia B: 10 years experience in a single centre
    Uprichard, J.
    Adamidou, D.
    Goddard, N. J.
    Yee, T. T.
    HAEMOPHILIA, 2011, 17 (02) : 360 - 360
  • [43] Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B
    Hewson, I. D.
    Makhmaloaf, P.
    AUSTRALIAN DENTAL JOURNAL, 2010, 55 (03) : 322 - 324
  • [44] Factor VIII deficiency not induced by FVIII gene mutation in a female first cousin of two brothers with haemophilia A
    Mazurier, C
    Parquet-Gernez, A
    Gaucher, C
    Lavergne, JM
    Goudemand, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) : 390 - 392
  • [45] Heteroduplex analysis in hemophilia B: Detection of two novel factor IX gene mutations
    Driscoll, MC
    Chu, A
    Hilgartner, MW
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 51 (04) : 324 - 327
  • [46] Factor IX Arg327ILE mutation resulting impaired affinity to FVIIIa as well as catalytic efficiency leads to severe haemophilia B
    Zhou, J.
    Dai, J.
    Wang, X.
    Yu, T.
    Lu, Y.
    Ding, Q.
    Wang, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 100 - 100
  • [47] Response to gene therapy in haemophilia B: Ranges of factor IX sustained after 3 years in HOPE-B etranacogene dezaparvovec gene therapy trial
    Hermans, Cedric
    Coppens, Michiel
    Le Quellec, Sandra
    Galante, Nicholas
    Drelich, Douglass
    Pipe, Steven
    HAEMOPHILIA, 2024, 30 : 25 - 25
  • [48] De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism
    Oldenburg, J
    Rost, S
    El-Maarri, O
    Leuer, M
    Olek, K
    Müller, CR
    Schwaab, R
    BLOOD, 2000, 96 (08) : 2905 - 2906
  • [49] A primate model for haemophilia B gene therapy research: Specific detection of human coagulation factor IX in cynomolgus macaques.
    Mimuro, F
    Ogata, K
    Mizukami, H
    Kikuchi, J
    Madoiwa, S
    Sugo, T
    Hanazono, Y
    Kume, A
    Yoshioka, A
    Ozawa, K
    Sakata, Y
    BLOOD, 2002, 100 (11) : 90B - 90B
  • [50] Abnormal bleeding phenotype for mild haemophilia B patients with the p.Ile112Thr variation on the gene for factor IX
    Row, Celine
    Chamouni, Pierre
    Berger, Claire
    Lienhart, Anne
    Meunier, Sandrine
    Fretigny, Mathilde
    Dalibard, Vincent
    Viprey, Marie
    Chambost, Herve
    Barbay, Virginie
    Bovet, Julien
    HAEMOPHILIA, 2021, 27 (04) : E462 - E465
12345